Thursday, June 23, 2016
- 12:00pm-1:30pm
-
Apraclonidine in the treatment of ptosis
Clinical trials and therapy in movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Aquatic physical therapy: Functional motor skills in people with Parkinson’s disease
Other · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Are Parkinson’s disease futility studies futile?
Clinical trials and therapy in movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Are we speaking the same language? A pilot study to evaluate the agreement in clinical phenotyping of children with cerebral palsy
Pediatric movement disorder · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Assessing vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Assessment of need for treatment with botulinum toxin type A in cervical dystonia patients
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Assessment of oral hygiene status before and after the use of powered tooth brush in patients with Parkinson’s diseases
Other · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Association analysis of NALCN polymorphisms rs1338041 and rs61973742 in a Chinese population with isolated cervical dystonia
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Association of amyotrophic lateral sclerosis with basal ganglia impairment
Other · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Association of Parkinson’s disease with essential tremor
Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 53
- Next Page»